Medicare Enrolled

Dr. Jonathan Raskin, M.D.

Pulmonary Disease · New York, NY
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
1000 PARK AVE, New York, NY 10028
2122884600
Registered in NPPES since 2005
NPI: 1538156989 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Raskin from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Raskin? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Raskin

Dr. Jonathan Raskin is a pulmonary disease specialist in New York, NY, with 20 years of NPI registration. Based on federal Medicare data, Dr. Raskin performed 1,670 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Raskin received a total of $306,105 from 32 pharmaceutical and/or device companies across 945 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Raskin is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years of NPI registration ▲ Top 25% volume in NY $306,105 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
1,670
Medicare services
Top 25% in NY for pulmonary disease
Not available
Unique patients (not deduplicated)
$47
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
342 $8 $10
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
293 $101 $158
Spirometry test before and after medication
A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication.
228 $32 $49
Nitric oxide gas level test
A test that measures the level of nitric oxide gas in the body.
202 $16 $24
Dexamethasone injection (steroid)
An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram.
154 $0 $0
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
89 $72 $112
Electrocardiogram (EKG), 12-lead
A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report.
85 $12 $18
Flu vaccine, high-dose
High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe.
61 $72 $75
Flu vaccine administration
This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient.
61 $35 $45
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
42 $135 $221
New patient office visit, complex (60-74 min) 33 $189 $273
Telephone medical discussion, 11-20 minutes
A phone conversation with a physician lasting between 11 and 20 minutes.
30 $45 $112
Pneumococcal conjugate vaccine (PCV20)
An intramuscular injection of the 20-valent pneumococcal conjugate vaccine. It is used to protect against diseases caused by Streptococcus pneumoniae bacteria.
25 $282 $325
Pneumonia vaccine administration
This procedure involves the injection of a vaccine to protect against pneumococcal disease. It is administered by a healthcare provider.
25 $35 $43
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$306,105
Total received (2018-2024)
Avg $43,729/year across 7 years
Top 1% in NY for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
32
Companies
945
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$37,559
2023
$75,567
2022
$36,367
2021
$33,660
2020
$48,066
2019
$71,410
2018
$3,476

Payments by company (2024)

GlaxoSmithKline, LLC.
$36,405
AstraZeneca Pharmaceuticals LP
$418
GENZYME CORPORATION
$264
Regeneron Healthcare Solutions, Inc.
$123
Insmed, Inc.
$92
Amgen Inc.
$79
Novo Nordisk Inc
$56
Grifols USA, LLC
$41
Lilly USA, LLC
$28
Merck Sharp & Dohme LLC
$21
Electromed, Inc.
$18
Boehringer Ingelheim Pharmaceuticals, Inc.
$14
Top 3 companies account for 98.7% of 2024 payments
All-time payments by company (2018-2024) ›
GlaxoSmithKline, LLC.
$287,550
AstraZeneca Pharmaceuticals LP
$6,686
Boehringer Ingelheim Pharmaceuticals, Inc.
$4,221
Mylan Specialty L.P.
$2,020
Insmed, Inc.
$1,057
GENZYME CORPORATION
$1,044
Mallinckrodt Hospital Products Inc.
$390
Amgen Inc.
$347
Merck Sharp & Dohme Corporation
$304
Lilly USA, LLC
$281
Regeneron Healthcare Solutions, Inc.
$280
Grifols USA, LLC
$249
Janssen Pharmaceuticals, Inc
$241
SANOFI-AVENTIS U.S. LLC
$234
Teva Pharmaceuticals USA, Inc.
$209
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$178
Electromed, Inc.
$154
Circassia Pharmaceuticals Inc
$97
Sunovion Pharmaceuticals Inc.
$75
Covis Pharma GmBH
$61
PFIZER INC.
$57
Novo Nordisk Inc
$56
Allergan Inc.
$55
Pulmonx Corporation
$47
AbbVie, Inc.
$45
SANOFI PASTEUR INC.
$40
Merck Sharp & Dohme LLC
$35
Genentech USA, Inc.
$23
IDORSIA PHARMACEUTICALS US INC
$20
Alexion Pharmaceuticals, Inc.
$20
Shire North American Group Inc
$17
Kowa Pharmaceuticals America, Inc.
$14
Top 3 companies account for 97.5% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ADACEL · AIRSUPRA · AJOVY · ALVESCO · ANORO · ANORO ELLIPTA · AREXVY · AirDuo Digihaler · Arikayce · BEVESPI AEROSPHERE · BREO · BREZTRI · BREZTRI AEROSPHERE · CHARTIS CATHETER · CINQAIR · Creon · DUPIXENT · Dymista · FASENRA · FLUZONE QUADRIVALENT · GARDASIL · GARDASIL 9 · GLASSIA · JANUVIA · JARDIANCE · LONHALA MAGNAIR · Livalo · MOUNJARO · NAMZARIC · NUCALA · OFEV · Ozempic · PNEUMOVAX 23 · PRALUENT · PREVNAR 13 · PREVNAR 20 · Perforomist · ProAir Digihaler · Prolastin-C Liquid · QUVIVIQ · QVAR · Rybelsus · SHINGRIX · SMARTVEST · SPIRIVA · SPIRIVA RESPIMAT · STIOLTO · STIOLTO RESPIMAT · SYMBICORT · Strensiq · TEZSPIRE · TRELEGY ELLIPTA · TRULICITY · TUDORZA PRESSAIR · Utibron · XARELTO · XIFAXAN · XIFAXANIBSD · Xofluza · Yupelri · ZERBAXA
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a pulmonary disease specialist in New York?
Compare pulmonary diseases in the New York area by procedure volume, costs, and industry payment transparency.
Browse pulmonary diseases nearby

Geographic Context

Pulmonary diseases in nearby ZIP areas
664
County median income
$104,553
Nearest hospital to ZIP centroid (approximate)
LENOX HILL HOSPITAL
0.3 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Raskin is a clinical cardiology specialist, with above-average Medicare volume (top 25% in NY), with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Raskin experienced with blood draw (venipuncture)?
Based on Medicare claims data, Dr. Raskin performed 342 blood draw (venipuncture) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Raskin receive payments from pharmaceutical companies?
Yes. Dr. Raskin received a total of $306,105 from 32 companies across 945 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Raskin's costs compare to other pulmonary diseases in New York?
Dr. Raskin's average Medicare payment per service is $47. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Raskin) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →